Tirzepatide 20mg is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for research applications in metabolic disorders. This synthetic peptide analogue demonstrates significant potential in diabetes and obesity research studies.
As a GIP and GLP-1 receptor agonist, tirzepatide 20mg works through multiple mechanisms including enhanced insulin secretion, reduced glucagon secretion, slowed gastric emptying, and increased satiety. These combined effects make it particularly interesting for metabolic research applications.
Our tirzepatide 20mg is produced under strict quality control standards in GMP-certified facilities. The white lyophilized powder is carefully packaged to ensure stability and purity throughout transportation and storage. Each batch undergoes comprehensive analytical testing including HPLC, mass spectrometry, and amino acid analysis to verify identity and purity.
For research purposes only. Not for human consumption. Proper handling procedures should be followed when working with peptide compounds in laboratory settings.
Fantastic experience with this supplier! From start to finish, everything was handled professionally. First, the shipping was incredibly fast—my order arrived well ahead of schedule, securely packaged to ensure the product's integrity. Furthermore, the quality of the items received appears top-notch, based on visual inspection and documentation provided. Finally, the customer service team was responsive and helpful, promptly answering my inquiries with clarity. For anyone in need of reliable research materials, this vendor is a solid choice. Five stars all around!